Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • News
    • News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
  • Toggle search form

[Disclosure] Hanwha Aerospace (012450) Discloses Details of KRW 351.8B Defense Export Agreement with KOTRA Following Expiration of Confidentiality Period

Posted on July 24, 2025July 20, 2026 By K-STOCK Editor No Comments on [Disclosure] Hanwha Aerospace (012450) Discloses Details of KRW 351.8B Defense Export Agreement with KOTRA Following Expiration of Confidentiality Period

Source Fact: Financial Supervisory Service Electronic Disclosure System (DART) / 2025-07-24

Disclosure Type: Execution of a Single Sales/Supply Contract (Amendment Related to Resolution of Non-disclosure)

💡 3-Second Summary

Hanwha Aerospace has fully disclosed the details of a supply contract worth approximately KRW 351.8B, named “Defense Export Implementation Agreement” with KOTRA, which was previously kept confidential since its initial execution on January 24, 2025.

📊 1. [Summary of Core Disclosure Content and Major Figures]

  • Reason for Amendment: Disclosure of previously omitted details following the expiration of the management confidentiality period (Initial filing date: January 24, 2025)
  • Contract Name & Classification: Defense Export Implementation Agreement (Product Supply)
  • Contract Amount: KRW 351,758,967,000 (approx. KRW 351.8B)
  • Ratio to Sales: Equivalent to 3.76% of the company’s 2023 consolidated annual revenue (KRW 9,359,005,981,309)
  • Counterparty & Region: Korea Trade-Investment Promotion Agency (KOTRA) / Republic of Korea
  • Contract Period:
    • Start Date: January 24, 2025
    • End Date: January 20, 2031
  • Valuation Baseline: The contract amount was converted into KRW based on the trading standard exchange rate of the Seoul Foreign Exchange Brokerage on January 24, 2025 (KRW 1,437.10/USD).
  • Key Terms: The presence of down payments and advance payments is confirmed (‘Yes’).

📈 2. [Expert Perspective: What This Disclosure Means for Investors]

This disclosure serves as a regulatory follow-up providing the specific conditions of the single sales/supply contract that were omitted for confidentiality until the expiration date of July 23, 2025. Following the resolution of this period, fields such as contract name, value, counterparty, location, and period have been updated with verified baseline entries.

The total contract value of approximately KRW 351.8B represents an administrative unveiling of an existing order rather than a newly finalized contract win, representing 3.76% of the 2023 consolidated revenue. The disclosure does not encompass text defining the accounting methods or revenue recognition timelines for this transaction. Investors can observe from the figures that the contract spans a long-term duration of approximately six years through January 20, 2031, and may treat potential adjustments to the contract value or duration during execution as independent checkpoints.

📝 Editor’s Comment (by K-STOCK Editor)

This amendment filing delivers only the factual disclosure that the contract details for the defense export agreement have been filled in due to the lifting of the confidentiality clause. The core text identifies the counterparty as KOTRA and the contract name as the Defense Export Implementation Agreement but omits granular information regarding the specific defense product lines or structural payment breakdown.

The primary checkpoints for investors to monitor going forward are the long-term execution milestones over the contract timeline. Given that the filing notes the final amounts and durations remain subject to change during the execution process and involves foreign currency conversion metrics (KRW 1,437.10/USD), cross-referencing future periodic statements to track remaining backlogs objectively will serve as the primary approach.

📢 Disclaimer & Source Information

Source: This content has been structured and newly generated based on the official data submitted to the Financial Supervisory Service Electronic Disclosure System (DART).

Investment Risk Notice: This information is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the individual investor.

Contact: For compliance-related inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Defense

Post navigation

Previous Post: [Disclosure] SK Square (402340) Resolves to Dispose of KRW 3.4 Billion Worth of Treasury Shares for Executive Compensation; Dilution Effect Minimal at 0.02%
Next Post: [Disclosure] SK Hynix (000660) Q2 2025 Operating Profit Surpasses 9.2T KRW, Skyrocketing 68.5% YoY

Related Posts

[Disclosure] Hanwha Ocean (042660) Announces Treasury Share Acquisition Plan Valued at KRW 5.1B for Employee RSU Incentives, Amending Daily Buy Order Limit Disclosures
[Disclosure] Alteogen(196170) Resolves to Submit Agenda for Conditional KOSDAQ Delisting and KOSPI Transfer to Shareholders’ Meeting Disclosures
[Disclosure] Celltrion (068270) Ordered to Pay KRW 12.7B in 1st Instance of Diagnostic Kit Suit Against Humasis; Plans to Appeal Disclosures
[Disclosure] Celltrion to Hold Hong Kong Investor Relations Conference via Live YouTube Broadcast (068270) Disclosures
[Disclosure] HANMI Semiconductor (042700) Posts Record-Breaking Q3 Operating Profit of 99.3 Billion KRW – Explosive +3,320% YoY Surge Driven by HBM Monopoly Semiconductors
[Disclosure] SAMSUNG BIOLOGICS(207940) Trading Briefly Suspended and Resumed on May 22 Following Major Corporate Split Announcement Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Alteogen (196170) Establishes August 6 as Record Date for Bonus Issue Share AllotmentJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Trading Suspension and Resumption Schedule for Stock Futures and OptionsJuly 16, 2026
  • [Disclosure] Alteogen (196170) Temporarily Suspends Plans for Relisting on the KOSPI MarketJuly 16, 2026
  • [Disclosure] Alteogen (196170) Announces Temporary Trading Suspension on July 16 Due to Bonus Issue DecisionJuly 16, 2026
  • [Disclosure] Alteogen (196170) Decides on Bonus Issue of 0.3 Shares per 1 Common and Preferred ShareJuly 16, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme